New Stavanger University Hospital - IO-9843 Colour instrument PD-L1 - SP142

Description

Stavanger Hospital Trust, c/o New SUS, intends to enter into a contract with Roche Diagnostics Norge AS for the delivery of instruments for immunohistochemistry/colour instrument PD-L1 SP142, including consumables for the New Stavanger University Hospital. Lot 1: Stavanger Hospital Trust, c/o New SUS, intends to enter into a contract with Roche Diagnostics Norge AS for the delivery of instruments for immunohistochemistry/colour instrument PD-L1 SP142, including consumables for the New Stavanger University Hospital. In accordance with the guidelines national action programme with guidelines for diagnostics, treatment, and follow-up of patients with breast cancer, the contracting authority understands that only Roche can deliver instrument PD-L1 SP142 Atezolizimumab in accordance with the guidelines (Ventana Benchmark Ultra Plus). The contracting authority has therefore obtained tender information directly from Roche, and intends to enter into a contract with them after the publication of this voluntary ex-ante transparency notice, provided that no objections are received within 10 days of this notice. Suppliers that have questions or input are encouraged to contact us will before the deadline.